Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Chuikyo Subcommittee to Review Pricing of Insurance-covered Medical Materials
November 17, 2003
- JT: Pharma Division Sales Down 4.3%
November 17, 2003
- JCQHC Warns Against High-concentration K Preparations, 10% Xylocaine
November 17, 2003
- Kyorin: Sales Down 3.3% due to Decline in Sales of Gatiflo
November 17, 2003
- Japan's Pacemaker Market Growing Around 10% Annually
November 17, 2003
- Fujisawa's Overseas Sales Exceed 50% of Total
November 17, 2003
- BULLETIN
November 17, 2003
- Semiannual Business Results
November 17, 2003
- MPC New Plan Aiming at Sales of \240 Bil. in FY2006: President Kobori
November 17, 2003
- REGULATORY NEWS IN BRIEF
November 17, 2003
- BULLETIN
November 17, 2003
- Economic and Financial White Paper Calls for Reforms to Optimize Medical Expenditure
November 17, 2003
- WORLD NEWS IN BRIEF
November 17, 2003
- ON THE MOVE
November 17, 2003
- DIAGNOSTIC NEWS IN BRIEF
November 17, 2003
- Societies Request Exemption of Expensive Drugs from Flat-sum Reimbursement System
November 17, 2003
- OTC NEWS IN BRIEF
November 17, 2003
- Daiichi: Cravit, Artist Contribute to Good Sales
November 17, 2003
- Soiken to Develop Biomarkers for Fatigue
November 17, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 17, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…